Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease
| Title: | Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease |
|---|---|
| Authors: | Sharma M.; Leung D.; Momenilandi M.; Jones L. C. W.; Pacillo L.; James A. E.; Murrell J. R.; Delafontaine S.; Maimaris J.; Vaseghi-Shanjani M.; Del Bel K. L.; Lu H. Y.; Chua G. T.; Di Cesare S.; Fornes O.; Liu Z.; Di Matteo G.; Fu M. P.; Amodio D.; Tam I. Y. S.; Chan G. S. W.; Sharma A. A.; Dalmann J.; Van Der Lee R.; Blanchard-Rohner G.; Lin S.; Philippot Q.; Richmond P. A.; Lee J. J.; Matthews A.; Seear M.; Turvey A. K.; Philips R. L.; Brown-Whitehorn T. F.; Gray C. J.; Izumi K.; Treat J. R.; Wood K. H.; Lack J.; Khleborodova A.; Niemela J. E.; Yang X.; Liang R.; Kui L.; Wong C. S. M.; Poon G. W. K.; Hoischen A.; Van Der Made C. I.; Yang J.; Chan K. W.; Da Rosa Duque J. S.; Lee P. P. W.; Ho M. H. K.; Chung B. H. Y.; Le H. T. M.; Yang W.; Rohani P.; Fouladvand A.; Rokni-Zadeh H.; Changi-Ashtiani M.; Miryounesi M.; Puel A.; Shahrooei M.; Finocchi A.; Rossi P.; Rivalta B.; Cifaldi C.; Novelli A.; Passarelli C.; Arasi S.; Bullens D.; Sauer K.; Claeys T.; Biggs C. M.; Morris E. C.; Rosenzweig S. D.; O’Shea J. J.; Wasserman W. W.; Bedford H. M.; Van Karnebeek C. D. M.; Palma P.; Burns S. O.; Meyts I.; Casanova J. L.; Lyons J. J.; Parvaneh N.; Van Nguyen A. T.; Cancrini C.; Heimall J.; Ahmed H.; McKinnon M. L.; Lau Y. L.; Béziat V.; Turvey S. E. |
| Contributors: | Sharma, M; Leung, D; Momenilandi, M; Jones, Lcw; Pacillo, L; James, Ae; Murrell, Jr; Delafontaine, S; Maimaris, J; Vaseghi-Shanjani, M; Del Bel, Kl; Lu, Hy; Chua, Gt; Di Cesare, S; Fornes, O; Liu, Z; Di Matteo, G; Fu, Mp; Amodio, D; Tam, Iy; Chan, Gsw; Sharma, Aa; Dalmann, J; Van Der Lee, R; Blanchard-Rohner, G; Lin, S; Philippot, Q; Richmond, Pa; Lee, Jj; Matthews, A; Seear, M; Turvey, Ak; Philips, Rl; Brown-Whitehorn, Tf; Gray, Cj; Izumi, K; Treat, Jr; Wood, Kh; Lack, J; Khleborodova, A; Niemela, Je; Yang, X; Liang, R; Kui, L; Wong, Csm; Poon, Gwk; Hoischen, A; Van Der Made, Ci; Yang, J; Chan, Kw; Da Rosa Duque, J; Lee, Ppw; Ho, Mhk; Chung, Bhy; Le, Htm; Yang, W; Rohani, P; Fouladvand, A; Rokni-Zadeh, H; Changi-Ashtiani, M; Miryounesi, M; Puel, A; Shahrooei, M; Finocchi, A; Rossi, P; Rivalta, B; Cifaldi, C; Novelli, A; Passarelli, C; Arasi, S; Bullens, D; Sauer, K; Claeys, T; Biggs, Cm; Morris, Ec; Rosenzweig, Sd; O’Shea, Jj; Wasserman, Ww; Bedford, Hm; Van Karnebeek, Cdm; Palma, P; Burns, So; Meyts, I; Casanova, Jl; Lyons, Jj; Parvaneh, N; Van Nguyen, At; Cancrini, C; Heimall, J; Ahmed, H; Mckinnon, Ml; Lau, Yl; Béziat, V; Turvey, Se |
| Publisher Information: | ROCKEFELLER UNIV PRESS |
| Publication Year: | 2023 |
| Collection: | Universitá degli Studi di Roma "Tor Vergata": ART - Archivio Istituzionale della Ricerca |
| Subject Terms: | Settore MED/38 |
| Description: | sharma et al. define a new primary atopic disorder caused by heterozygous gain-of-function variants in STAT6. this results in severe, early-onset allergies, and is seen in 16 patients from 10 families. Anti-IL-4R & alpha; antibody and JAK inhibitor treatment were highly effective.STAT6 (signal transducer and activator of transcription 6) is a transcription factor that plays a central role in the pathophysiology of allergic inflammation. we have identified 16 patients from 10 families spanning three continents with a profound phenotype of early-life onset allergic immune dysregulation, widespread treatment-resistant atopic dermatitis, hypereosinophilia with esosinophilic gastrointestinal disease, asthma, elevated serum IgE, IgE-mediated food allergies, and anaphylaxis. the cases were either sporadic (seven kindreds) or followed an autosomal dominant inheritance pattern (three kindreds). all patients carried monoallelic rare variants in STAT6 and functional studies established their gain-of-function (GOF) phenotype with sustained STAT6 phosphorylation, increased STAT6 target gene expression, and T(H)2 skewing. Precision treatment with the anti-IL-4R & alpha; antibody, dupilumab, was highly effective improving both clinical manifestations and immunological biomarkers. this study identifies heterozygous GOF variants in STAT6 as a novel autosomal dominant allergic disorder. We anticipate that our discovery of multiple kindreds with germline STAT6 GOF variants will facilitate the recognition of more affected individuals and the full definition of this new primary atopic disorder. |
| Document Type: | article in journal/newspaper |
| Language: | English |
| Relation: | info:eu-repo/semantics/altIdentifier/pmid/36884218; info:eu-repo/semantics/altIdentifier/wos/WOS:001017325000001; volume:220; issue:5; journal:JOURNAL OF EXPERIMENTAL MEDICINE; https://hdl.handle.net/2108/345923 |
| DOI: | 10.1084/jem.20221755 |
| Availability: | https://hdl.handle.net/2108/345923; https://doi.org/10.1084/jem.20221755; https://rupress.org/jem/article/220/5/e20221755/213926/Human-germline-heterozygous-gain-of-function-STAT6 |
| Rights: | info:eu-repo/semantics/openAccess ; license:Creative commons ; license uri:http://creativecommons.org/licenses/by/4.0/ |
| Accession Number: | edsbas.191B6D5F |
| Database: | BASE |